Evidence map›Paper›PMID 23416183›Full record

ArticleAnalytical biochemistry2013

A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease.

Beena Thomas, Samantha Matson, Vanita Chopra, Liping Sun, Swati Sharma, Steven Hersch, H Diana Rosas, Clemens Scherzer, Robert Ferrante, Wayne Matson

Abstract read
In one paragraph

Article in Analytical biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. DNA methylation in plant heterosis: mechanisms and prospects.Functional & integrative genomics · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Less Severe Polymicrobial Sepsis in ConditionalInternational journal of molecular sciences · 2023
    Article
  11. Less Severe Lipopolysaccharide-Induced Inflammation in ConditionalInternational journal of molecular sciences · 2023
    Article
  12. Review
  13. Article
  14. DNA Methylation in Huntington's Disease.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Mechanisms of protein toxicity in neurodegenerative diseases.Cellular and molecular life sciences : CMLS · 2018
    Review
  19. Review
  20. Contribution of Neuroepigenetics to Huntington's Disease.Frontiers in human neuroscience · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Beena ThomasDepartment of Systems Biochemistry, Bedford VA Medical Center, Bedford, MA 01730, USA.
Samantha Matson
Vanita Chopra
Liping Sun
Swati Sharma
Steven Hersch
H Diana Rosas
Clemens Scherzer
Robert Ferrante
Wayne Matson

Funding

Neuroimaging Biomarkers for disease-modyfying therapies in Hintington's diseaseP01NS058793 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI HERSCH, STEVEN M · 2008 to 2012
$6.6M
Biomarkers for early intervention in Parkinson diseaseU01NS082157 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI SCHERZER, CLEMENS R · 2012 to 2016
$2.5M
A Next Generation of Biomarkers for Incipient Huntington DiseaseU01NS082080 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI SCHERZER, CLEMENS R · 2013 to 2015
$1.5M
Prospective Neuroimaging in Huntington's DiseaseR56NS042861 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROSAS, HERMINIA DIANA · 2014 to 2014
$870k
NINDS NIH HHS P01 NS058793NINDS NIH HHS P01NS058793NINDS NIH HHS R56 NS042861NINDS NIH HHS U01 NS082080NINDS NIH HHS U01 NS082157
6 · The paper itself

Abstract

Guanine methylation is a ubiquitous process affecting DNA and various RNA species. N-7 guanine methylation (7-MG), although relatively less studied, could have a significant role in normal transcriptional regulation as well as in the onset and development of pathological conditions. The lack of a sensitive method to accurately quantify trace amounts of altered bases such as 7-MG has been a major deterrent in delineating its biological function(s). Here we report the development of methods to detect trace amounts of 7-MG in biological samples using electrochemical detection combined with high-performance liquid chromatography (HPLC) separation of compounds. We further sought to assess global alterations in DNA methylation in Huntington disease (HD), where transcriptional dysregulation is a major factor in pathogenesis. The developed method was used to study guanine methylation in cytoplasmic and nuclear nucleic acids from human and transgenic mouse HD brain and controls. Significant differences were observed in the guanine methylation levels in mouse and human samples, consistent with the known transcriptional pathology of HD. The sensitivity of the method makes it capable of detecting subtle aberrations. Identification of changes in methylation pattern will provide insights into the molecular mechanism changes that translate into onset and/or development of symptoms in diseases such as HD.

Indexed as

DNA MethylationAnimalsBrainCalibrationCase-Control StudiesCell NucleusChromatography, High Pressure LiquidCytoplasmElectrochemistryFemaleGuanineHumansHuntington DiseaseMaleMiceMice, Transgenic7-methylguanineGuanine

Identifiers

PMID23416183
PMCPMC4090024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.